MedTrace Logo

Preconditioning With Sevoflurane and Propofol in Patients Undergoing Minimally Invasive Mitral Valve Surgery

NCT02551328 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2015-09-16

No results posted yet for this study

Summary

The main aim of this study is to compare markers of cardiac injury (Troponin I), inflammatory response and platelets function during minimally invasive mitral valve repair or replacement (MIMV) via right mini-thoracotomy in two standard anaesthetic regimes (sevo \\propofol)

Conditions

  • Myocardial Ischemia

Interventions

DRUG

sevofluorane

Continuous infusion of sevofluorane

Sponsors & Collaborators

  • Fondazione Toscana Gabriele Monasterio

    lead OTHER

Principal Investigators

  • Paolo Del Sarto, MD · Fondazione Toscana Gabriele Monasterio

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-03-31
Completion
2016-09-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02551328 on ClinicalTrials.gov